NasdaqGM - Nasdaq Real Time Price USD
Vanda Pharmaceuticals Inc. (VNDA)
At close: October 22 at 4:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-5,141.0000
12,801.0000
31,984.0000
64,214.0000
51,775.0000
--
Investing Cash Flow
-41,936.0000
-12,056.0000
49,925.0000
-76,696.0000
-41,499.0000
--
Financing Cash Flow
--
--
734.0000
3,550.0000
5,634.0000
--
End Cash Position
103,423.0000
136,290.0000
135,498.0000
52,590.0000
61,613.0000
--
Capital Expenditure
-392.0000
-383.0000
-679.0000
-552.0000
-1,795.0000
--
Free Cash Flow
-5,533.0000
12,418.0000
31,305.0000
63,662.0000
49,980.0000
--
12/31/2019 - 4/12/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EYEN Eyenovia, Inc.
0.5429
-2.18%
MGTX MeiraGTx Holdings plc
5.98
-0.17%
KZR Kezar Life Sciences, Inc.
0.7800
-1.55%
ATRA Atara Biotherapeutics, Inc.
9.05
-2.37%
ARQT Arcutis Biotherapeutics, Inc.
8.34
+0.36%
SGMT Sagimet Biosciences Inc.
5.90
+5.92%
RGNX REGENXBIO Inc.
9.59
-7.52%
EXEL Exelixis, Inc.
28.83
+0.59%
IMRX Immuneering Corporation
2.2000
+1.85%
QURE uniQure N.V.
6.65
+0.76%